XML 32 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value
A summary of financial instruments measured at fair value was as follows (in thousands):
September 30, 2025Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$36,562 $— $— $36,562 
Certificates of deposit1,478 — — 1,478 
Endospan Loans  10,762 10,762 
Total assets$38,040 $ $10,762 $48,802 
Liabilities:
Current portion of contingent consideration$— $— $18,730 $18,730 
Non-current contingent consideration— — 36,540 36,540 
Total liabilities$ $ $55,270 $55,270 
December 31, 2024Level 1Level 2Level 3Total
Cash equivalents:
Money market funds$18,182 $— $— $18,182 
Certificates of deposit5,069 — — 5,069 
Endospan Loans— — 9,535 9,535 
Total assets$23,251 $ $9,535 $32,786 
Long-term liabilities:
Contingent consideration$— $— $52,880 $52,880 
Total liabilities$ $ $52,880 $52,880 
Schedule of Reconciliation of Changes in Fair Value of Level 3 Liabilities Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):
Contingent Consideration
Balance as of December 31, 2024$52,880 
Change in valuation 2,390 
Balance as of September 30, 2025$55,270 
Endospan Loans
Balance as of December 31, 2024$9,535 
Change in valuation 1,227 
Balance as of September 30, 2025$10,762